CNS PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01. Regulation FD Disclosure.

Representatives of CNS Pharmaceuticals, Inc. (the "Company") will use the presentation set forth as Exhibit 99.1 herein in connection with various meetings from time to time with the investment community.

The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference..

Item 9.01. Financial Statements and Exhibits

(d) Exhibits



  Exhibit No. Exhibit Description

  99.1          CNS Pharmaceuticals, Inc. Investor Presentation - May 2021




















  2

© Edgar Online, source Glimpses